Monique Arpin

Title: Monique Arpin: Innovator in Colorectal Cancer Diagnostics

Introduction

Monique Arpin is a distinguished inventor based in Paris, France. She has made significant contributions to the field of medical diagnostics, particularly in the early detection of colorectal cancer. With a total of six patents to her name, her work has the potential to impact patient outcomes positively.

Latest Patents

Monique Arpin's latest patents include innovative methods for the in vitro diagnosis of colorectal cancer. One of her notable inventions is the I-Plastin assay method, which determines the presence of the I-Plastin tumor marker in biological samples from patients suspected of having colorectal cancer. This method is designed for early diagnosis, screening, therapeutic follow-up, and prognosis, as well as for diagnosing relapses related to colorectal cancer. Another significant patent is the Ezrin assay method, which utilizes anti-Ezrin monoclonal antibodies to detect the Ezrin tumor marker in patient samples. This method also serves similar purposes in the diagnosis and management of colorectal cancer.

Career Highlights

Throughout her career, Monique has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and the Institut Pasteur. Her research and innovations have garnered attention in the medical community, showcasing her dedication to improving cancer diagnostics.

Collaborations

Monique has collaborated with esteemed colleagues, including Daniel Louvard and Eric Pringault. These partnerships have further enriched her research and contributed to the advancement of her patented methods.

Conclusion

Monique Arpin's contributions to colorectal cancer diagnostics through her innovative patents highlight her role as a leading inventor in the medical field. Her work not only enhances early detection but also improves the overall management of colorectal cancer, ultimately benefiting patients worldwide.